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20 Objective. Erythropoietin - a hormone regulating erythropoiesis - is a biomarker of chronic 
22 
23 fetal hypoxia. High erythropoietin levels in fetal plasma and amniotic fluid are associated 
24 
25 with increased risk of adverse neonatal outcome. Since the risk of perinatal morbidity and 
26 
27 
28 mortality is increased in pregnancies beyond 41 gestational weeks, we evaluated 
29 
30 erythropoietin levels in amniotic fluid and umbilical cord serum in apparently low-risk term 
31 
32 





38 Study Design. This prospective cohort study comprised 93 singleton pregnancies at 37+0-42+1 
39 
40 
41 gestational weeks, of which prolonged pregnancies numbered 63 (67.7%). Amniotic fluid 
42 
43 samples were collected at time of labor induction by amniotomy. Umbilical cord blood 
44 
45 
samples for evaluation of pH, base excess, and umbilical cord serum erythropoietin were 
47 
48 collected at birth. Erythropoietin levels were measured by immunochemiluminometric assay. 
49 
50 
Normal value of amniotic fluid erythropoietin level was defined as ≤3 IU/L, and abnormal 
52 
53 value as ≥27 IU/L. Normal umbilical cord serum erythropoietin was defined as <40 IU/L. 
54 
55 Data on maternal pregnancy and delivery characteristics and short-term neonatal outcomes 
57 






























using Spearman’s rank correlation coefficient. The Chi-square test, Fisher’s exact test and the 
1 




Results.  Amniotic  fluid  erythropoietin  levels  correlated  with  gestational  age  (r=0.261, 
7 
8 p=0.012) and were higher among prolonged pregnancies as compared to term pregnancies 
9 
10 
(p=0.005). There were  78 (83.9%) vaginal deliveries, and among these  erythropoietin levels 
12 
13 in amniotic fluid correlated with the levels in umbilical cord serum (r=0.513, p<0.000). 
14 
15 Umbilical cord serum erythropoietin levels correlated with gestational age among vaginal 
16 
17 
18 deliveries (r=0.250, p=0.027). Erythropoietin levels in amniotic fluid and umbilical cord 
19 






26 Conclusions. In vaginal deliveries erythropoietin levels in amniotic fluid correlated with the 
27 
28 levels in umbilical cord serum. Erythropoietin levels correlated with gestational age, probably 
30 
31 due to weakening placental function and relative hypoxemia occurring in advanced gestation. 
32 
33 However, in this relatively low-risk study population erythropoietin was not related to 
34 
35 






42 Keywords. Prolonged pregnancy, fetal erythropoietin, amniotic fluid, intrauterine hypoxia, 
43 
44 

























3 The risk of perinatal morbidity and mortality increase in pregnancies beyond 41 gestational 
4 
5 
weeks  [1,2].  The  underlying  mechanism  is  assumed  to  be  aging  of  the  placenta  and 
7 
8 subsequent relative placental insufficiency, thus predisposing the fetus to hypoxia. However, 
9 
10 
it is challenging to identify specific pregnancies at risk of intrapartum fetal compromise and 
12 
13 adverse outcomes. Numerous methods, such as fetal Doppler parameters and computerized 
14 
15 cardiotocography, are used to monitor placental function and fetal wellbeing. Nevertheless, 
16 
17 
18 these methods have not been demonstrated to be efficacious in predicting the outcomes of 
19 




Erythropoietin (EPO), a hormone regulating erythropoiesis, increases in response to fetal 
25 
26 hypoxia [6]. EPO levels in amniotic fluid correlate well with levels in fetal plasma prior to 
27 
28 the onset of labor contractions [7]. Increased EPO levels in amniotic fluid and umbilical cord 
30 
31 serum occur in various complicated pregnancies [7]. High EPO levels have been associated 
32 
33 with an increased risk of acute adverse neonatal outcomes, such as decreased umbilical artery 
34 
35 
36 pH and base excess (BE), and need for intensive care admission [7,8]. Thus, amniotic fluid 
37 
38 EPO is used as a biomarker of chronic fetal hypoxia. We hypothesized that an evaluation of 
39 
40 
amniotic fluid EPO level prior to labor could be used to identify the individuals at risk of 
42 
43 intrapartum distress, based on the assumption that the mechanism associated with adverse 
44 
45 
outcomes in prolonged pregnancies relates to hypoxia. 
47 
48 
49 The objective of the current study was to evaluate a correlation between EPO levels in 
50 
51 amniotic fluid and those in the umbilical cord serum in apparently low-risk term and 
52 
53 
prolonged pregnancies, and to investigate whether EPO level in amniotic fluid was predictive 
55 



















Materials and methods 
1 
2 
3 The  study  was  conducted  at  the  Department  of  Obstetrics  and  Gynecology,  Helsinki 
4 
5 
University  Hospital,   Finland.   Women   undergoing   singleton   pregnancies   with planned 
7 
8 induction of labor by amniotomy at ≥ 37+0 gestational weeks between September 2012 and 
9 
10 
December 2014 were recruited. Indications for induction were a prolonged pregnancy (≥ 41+0 
12 
13 gestational weeks), fear of childbirth, maternal exhaustion, mild pregnancy-induced 
14 
15 hypertension, complications in a previous pregnancy, high-pool rupture of membranes in the 
16 
17 
18 absence of delivery contractions, diet-controlled gestational diabetes, suspicion of large-for- 
19 
20 gestational age fetus in a non-diabetic mother, unstable presentation, polyhydramnios, or 
21 
22 
intrahepatic cholestasis of pregnancy. Women with severe pregnancy complications – such as 
24 
25 pre-eclampsia, intrauterine growth restriction, pre-gestational diabetes, medically treated 
26 
27 
gestational diabetes, Rhesus alloimmunization, and signs of infection or fetal distress before 
29 
30 labor – were excluded owing to the increased risk of fetal hypoxia and associated elevated 
31 
32 EPO levels [7]. 
34 
35 
36 Amniotic fluid samples were collected from 121 women at induction of labor by amniotomy 
37 
38 (Figure 1). Two pregnancies were excluded owing to neonatal diagnoses of VACTERL 
39 
40 
syndrome and nonketotic hyperglycinemia. The deliveries with both amniotic fluid and 
42 
43 umbilical cord serum EPO samples available (n=93) were included in the final analysis. The 
44 
45 
deliveries lacking umbilical cord serum EPO measurements (n=26) were also analysed to 
47 
48 avoid selection bias. They did not differ from the study group in terms of amniotic fluid EPO 
49 
50 levels (p=0.887), number of cesarean section deliveries (p=1.000), umbilical artery pH or BE 
51 
52 
53 (p=0.066 and p=0.703, respectively), or low Apgar score (≤7 at one or five minutes) (p=1.000 
54 
55 for both). Women with vaginal deliveries were divided into two groups, term (≥ 37+0- 40+6 
56 
57 
gestational weeks) and prolonged pregnancies (≥ 41+0 gestational weeks), for data analysis 
59 



















criteria applied: umbilical artery pH ≤7.15, umbilical artery BE ≤ -12meq/L, one or five- 
1 




6 Gestational  age  was  defined  by  the  fetal  crown-rump  length  measurement  at  the  first 
7 
8 trimester  ultrasound  screening.  Data  on  maternal  pregnancy  and  delivery  characteristics 
9 
10 
(body mass index [BMI] in early pregnancy, in vitro fertilization, parity, gestational diabetes 
12 
13 diagnosed by using oral glucose tolerance test, smoking, the main indication for cesarean 
14 
15 
section) and short-term neonatal outcomes (Apgar score at one and five minutes, umbilical 
17 
18 artery pH and BE, birthweight, and gestational age) were obtained from the hospital charts. 
19 
20 
21 The EPO levels were measured using a solid-phase immunochemiluminometric assay 
23 
24 (Immulite® 2000 XPi, Siemens, Tarrytown, USA). The intra-assay coefficient of variation 
25 
26 (CV) was 3.6-6.8% and the total CV was 6.4-10.3% for the concentration range 4-615 IU/L. 
27 
28 
29 The detection limit of the assay was 1.0 IU/L, with functional sensitivity (CV of 20%) of 1.5 
30 
31 IU/L. The classification of amniotic fluid EPO levels into three categories (normal- 
32 
33 
intermediate-abnormal) has been described previously [6,10]. A normal value of amniotic 
35 
36 fluid EPO level is defined as < 3 IU/L, and a value of > 27 IU/L is defined as abnormal 
37 
38 
[6,10]. A normal umbilical cord serum EPO is defined as < 40 IU/L [7]. The amniotic fluid 
40 
41 EPO values were analyzed after birth and they were not used in the clinical management of 
42 
43 the deliveries. The umbilical cord serum EPO values were measured from blood samples 
44 
45 
46 collected from the umbilical cord at birth. Measurements of umbilical artery pH and BE were 
47 
48 routinely performed with Radiometer ABL800 Flex blood gas analyzer (Radiometer, 
49 
50 
51 Copenhagen, Denmark). 
52 
53 
54 To determine a correlation between vaginally obtained amniotic fluid samples and amniotic 
55 
56 



















patients undergoing amniocentesis for fetal lung maturation assessment followed by an 
1 




6 Statistics. Statistical analysis was performed using Statistical Package for Social Sciences® 
7 
8 version 22.0 (SPSS Inc., Chicago, USA). Associations between the pH, BE, and EPO values 
9 
10 
were calculated using Spearman’s rank correlation coefficient. The Chi-square test, Fisher’s 
12 
13 exact test and the Mann-Whitney U test were utilized to determine significant differences in 
14 
15 
the study populations, when appropriate. A probability (p) value of <0.05 was considered 
17 
18 statistically significant. 
19 
20 
21 Ethical approval. Approval to conduct the study was obtained from the local research ethics 
22 
23 
24 committee (Ref no: 105/13/03/03/2012), Department of Obstetrics and Gynaecology, 
25 
26 Helsinki University Hospital, Finland. All participants provided informed written consent to 
27 
28 









38 The study population comprised 93 women for whom both amniotic fluid and umbilical cord 
39 
40 
41 blood samples were available. The demographic and clinical characteristics of the study 
42 





48 The median level of amniotic fluid EPO was 5.9 IU/L (range 0.5-89.8 IU/L) and that of 
49 
50 
umbilical cord serum EPO 32.9 IU/L (range 8.0-664.0 IU/L). The amniotic fluid EPO levels 
52 
53 correlated with the EPO levels in umbilical cord serum (r=0.480, p<0.000) and with 
54 
55 gestational age (r=0.261, p=0.012). Among the 63 (68%) prolonged pregnancies amniotic 
56 
57 


















IU/L, respectively) (p=0.005). The amniotic fluid EPO level was abnormal in three of the 
1 
2 pregnancies (one term and two prolonged pregnancies) (3%); with levels of 58.2 IU/L, 46.5 
3 
4 
5 IU/L and 89.8 IU/L, respectively. 
6 
7 Composite  adverse  outcomes  were  reported  for  18  of  the  deliveries  (19%)  (Table  1). 
8 
9 
Amniotic fluid EPO levels were not higher among these pregnancies as compared with the 
11 
12 pregnancies without adverse outcomes (p=0.903). No difference in adverse outcomes was 
13 
14 
observed between the term and prolonged pregnancies (p=0.162). Amniotic fluid EPO levels 
16 






23 Vaginal delivery occurred in 78 (84%) pregnancies. EPO levels in amniotic fluid and 
24 
25 umbilical cord serum did not differ between vaginal delivery and cesarean section patients 
26 
27 
28 (amniotic fluid EPO median 6.0 IU/L [range 0.5-58.2 IU/L] and 5.8 [range 1.6-89.8 IU/L] 
29 
30 respectively, p=0.350; umbilical cord serum EPO median 32.7 [range 8.0-178.0 IU/L] and 
31 
32 
32.9 [range 13.0-664.0 IU/L] respectively, p=0.222). Indications for an emergency cesarean 
34 
35 section were fetal distress (n=3), labor dystocia (n=7), chorioamnionitis (n=4), and fetal 
36 
37 malpresentation (n=1) (Figure 1). Both the amniotic fluid EPO level (89.8 IU/L) and the 
39 
40 umbilical cord serum EPO level (340.0 IU/L) were clearly abnormal in one patient 
41 
42 undergoing a cesarean section for intrapartum fetal distress. In the other two cases with fetal 
43 
44 
45 distress umbilical cord serum EPO levels were abnormal (89.2 and 664.0 IU/L). None of 
46 




51 Umbilical cord serum EPO levels correlated with gestational age among vaginal deliveries 
52 
53 (r=0.250, p=0.027), but the levels were not higher in prolonged pregnancies than in term 
54 
55 
pregnancies (p=0.057, Table 2). Umbilical cord serum EPO levels were abnormal in 28 
57 


















Umbilical cord serum EPO levels did not correlate with umbilical artery pH, BE, duration of 
1 
2 the delivery, or duration of the second stage of the delivery (p=0.897, p=0.390, p=0.287, and 
3 
4 







The current study demonstrates that amniotic fluid EPO levels could be measured from 
13 
14 samples obtained at induction of labor by amniotomy. EPO levels in amniotic fluid correlated 
15 
16 with gestational age in both term and prolonged pregnancies and were higher among 
17 
18 
19 prolonged pregnancies. Amniotic fluid EPO levels correlated with umbilical cord serum EPO 
20 
21 levels, even after the stress caused by vaginal delivery. Nevertheless, neither amniotic fluid 
22 
23 
24 EPO nor umbilical cord serum EPO level correlated with umbilical artery pH or BE. In this 
25 
26 relatively small study population of apparently low-risk term and prolonged pregnancies with 
27 
28 
induction of labor delivery, amniotic fluid EPO levels were not associated with adverse 
30 




35 The primary indication for the induction of labor might have affected the perinatal outcomes. 
36 
37 However, pregnancies complicated by conditions involving increased risk of fetal hypoxia 
38 
39 
and adverse outcomes were not included in this study. The number of umbilical cord serum 
41 
42 EPO samples collected from the study patients was limited and this reduced the sample size 
43 
44 considerably, thus possibly influencing the results. Nevertheless, the outcomes of the group 
46 
47 lacking umbilical cord serum EPO samples and those of the study population were similar. 
48 
49 The sample size was too limited to analyze rarely occurring adverse perinatal outcomes in 
50 
51 
52 low-risk population. This probably explains why this study failed to demonstrate that 
53 






















High levels of amniotic fluid EPO reflect chronic hypoxia and are associated with adverse 
1 
2 perinatal  outcomes  in  complicated  pregnancies,  such  as  those  characterized  by  Rhesus 
3 
4 
5 alloimmunization, fetal growth restriction, pre-eclampsia, and maternal type 1 diabetes [7]. 
6 
7 Fetal  EPO  levels  are  assumed  to  be  relatively  stable  after  the  second  trimester  during 
8 
9 
normoxic conditions [11], but increased levels have been reported beyond 41 gestational 
11 
12 weeks [12]. Consistent with this, we observed higher levels of amniotic fluid EPO in 
13 
14 
prolonged pregnancies compared to term pregnancies. This is in agreement with the 
16 
17 assumption that incipient weakening of placental function and relative chronic hypoxia 
18 




23 Adverse perinatal outcomes, such as low Apgar score and decreased arterial pH and BE 
24 
25 levels, intrapartum distress, and meconium aspiration, are more common in late term and 
27 
28 prolonged pregnancies [1,8,13]. However, in the current study both adverse outcome events 
29 
30 and abnormal amniotic fluid EPO values were rare. This might reflect efficient fetal 
31 
32 
33 compensatory mechanisms among these pregnancies, which in part might explain why it was 
34 






41 EPO levels in the fetal plasma begin to rise soon after a hypoxic event, several hours before 
42 
43 
44 they rise in the amniotic fluid [7]. Thus, elevated EPO levels in the umbilical cord blood may 
45 
46 reflect subacute hypoxia caused by adverse events during delivery. Only a few abnormal 
47 
48 
blood gas values occurred in the current study, which probably explains the lack of 
50 
51 correlation of umbilical cord serum EPO with pH and BE levels. 
52 
53 
54 A correlation between the EPO level in amniotic fluid and that in fetal plasma has previously 
55 
56 





















contractions [7]. We demonstrated that this correlation persists even after variable fetal stress 
1 




The mode of the delivery is known to affect umbilical cord serum EPO level, with higher 
7 
8 values occurring following vaginal birth as compared to planned cesarean sections [7,14]. No 
9 
10 
such difference was found in the current study. This is biologically plausible,  considering the 
12 
13 exposure of all the neonates to delivery contractions. Umbilical cord serum EPO levels did 
14 
15 not correlate with the duration of the labor nor that of the second stage of the labor in the 
16 
17 
18 current study. This is consistent with the findings of a recent study on term asphyxiated 
19 




Umbilical cord serum EPO levels correlated with gestational age, but the difference in this 
25 
26 regard between term and prolonged pregnancies was not significant. This is reasonable, 
27 
28 considering that the risk of adverse perinatal outcomes in term pregnancies increases 
30 
31 gradually, without a specific gestational age threshold [16]. Abnormal umbilical cord serum 
32 
33 EPO levels occurred in a substantial proportion of the study population, even though the 
34 
35 
36 neonatal outcomes were normal in most of the cases. Nevertheless, umbilical cord serum 
37 
38 EPO levels were abnormal in all cesarean sections performed for fetal distress. The 
39 
40 
significance of the current study findings, along with an exploration of the normal range of 
42 
43 umbilical cord serum EPO levels in low-risk populations, needs to be validated in further 
44 
45 
studies with larger sample size. 
47 
48 
49 EPO levels in amniotic fluid samples collected at amniotomy proved to be consistent with 
50 
51 those measured in samples obtained by amniocentesis, which, to the best of our knowledge, is 
53 
54 a novel observation. The advantage of vaginally obtained samples is the noninvasive method. 
55 



















terms of outcomes in this relatively low-risk population, its usefulness in this regard in high- 
1 







9 An evaluation of EPO level in amniotic fluid can be safely performed from samples obtained 
11 
12 by amniotomy at induction of labor. In the current study amniotic fluid EPO levels correlated 
13 
14 with gestational age in term and prolonged pregnancies and were higher in prolonged 
15 
16 
17 pregnancies compared to term pregnancies. Umbilical cord serum EPO levels correlated with 
18 
19 amniotic fluid EPO levels, even after vaginal delivery. In this study on apparently low-risk 
20 
21 
22 pregnancies,   however, amniotic fluid EPO was not related to adverse outcomes. 
23 
24 Consequently, an evaluation of EPO level in amniotic fluid may not be a useful routine for 
25 
26 
the assessment of fetal well-being in low-risk pregnancies with induction of labor. Future 
28 
29 studies on amniotic fluid EPO assessment at amniotomy or spontaneous rupture of 
30 
31 
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Table 1. The demographic and clinical characteristics of the study population (n = 93) 
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Characteristics n (%) 
Maternal age, mean (SD) 30.6 (5.4) 
BMI, mean (SD) 24.1 (5.3) 
Prolonged pregnancy (≥ 41+0 GW) 63 (67.7) 
Nulliparity 35 (37.6) 
Gestational diabetes 11 (11.8) 
In vitro fertilization 3 (3.2) 







Vacuum extraction 4 (4.3) 
Cesarean section 15 (16.1) 
Adverse outcomes 18 (19.4) 
Umbilical artery pH ≤ 7.15 13 (14.0) 
Umbilical artery BE ≤ -12 2 (2.2) 
1 or 5 min Apgar < 7 5 (5.4) 
Cesarean section for fetal distress 3 (3.2) 
Birth weight (g), mean (SD) 3797 (422) 
SD: standard deviation   
BMI: body mass index   
GW: gestational weeks   
BE: base excess   
Table 2 
Term pregnancies Prolonged pregnancies 
37+0 - 40+6 GW  ≥ 41+0 GW 
n = 23 (29.5%) n = 55 (70.5%) 
 median IR median IR p-valuea 
Amniotic fluid EPO 3.9 2.7 to -6.2 7.1 4.6 to 11.3 0.026 
Umbilical artery pH 7.32 7.24 to 7.36 7.26 7.16 to 7.32 0.017 
Umbilical artery BE -4.5 -6.1 to -2.2 -5.5 -7.0 to -3.1 0.145 
Umbilical serum EPO 20.3 11.5 to 51.5 34.0 23.6 to 55.7 0.057 
Duration of the delivery (minutes) 290 201 to 577 427 241 to 612 0.070 
Duration of the 2nd stage of the delivery (minutes) 18 10 to 32 17 8 to 40 0.900 
aMann Whitney U-test      
GW: gestational weeks, IR: interquartile range, BE: base excess, EPO: erythropoietin 
Figure 1 
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